ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE. Asian Journal of Medical Research and Health Sciences, [S. l.], v. 4, n. 2, p. 1398–1403, 2026. Disponível em: https://ajmrhs.com/journal/article/view/617. Acesso em: 1 jul. 2026.